ACADIA Pharmaceuticals (ACAD) News Today $23.61 -0.59 (-2.44%) Closing price 09/12/2025 04:00 PM EasternExtended Trading$23.66 +0.05 (+0.22%) As of 09/12/2025 07:42 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock ACAD Latest News All Sources Trusted Sources MarketBeat Barchart Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent September 2025 August 2025 July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 Time Period ACADIA Pharmaceuticals (ACAD) Reports Positive Interim Results From Rett Syndrome StudySeptember 13 at 3:08 PM | finance.yahoo.comTD Cowen Forecasts Strong Price Appreciation for ACADIA Pharmaceuticals (NASDAQ:ACAD) StockSeptember 13 at 9:39 AM | marketbeat.comAnalysts Offer Insights on Healthcare Companies: Exact Sciences (EXAS) and ACADIA Pharmaceuticals (ACAD)September 12 at 9:27 PM | theglobeandmail.comReal World Data from LOTUS Study Evaluating Long-term Efficacy and Tolerability Outcomes of DAYBUE® (trofinetide) in Patients with Rett Syndrome Published in Developmental Medicine and Child NeurologySeptember 12 at 4:05 PM | businesswire.comACADIA Pharmaceuticals (NASDAQ:ACAD) Stock Price Expected to Rise, TD Cowen Analyst SaysSeptember 12 at 3:19 AM | americanbankingnews.comACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) Receives $28.88 Average PT from BrokeragesSeptember 12 at 2:49 AM | americanbankingnews.comAcadia Pharmaceuticals price target raised to $39 from $35 at TD CowenSeptember 11 at 8:35 PM | msn.comACADIA Pharmaceuticals Inc. (ACAD) Nears Key Phase 3 Readout in Prader-Willi SyndromeSeptember 11 at 8:35 PM | finance.yahoo.comUBS Group Issues Positive Forecast for ACADIA Pharmaceuticals (NASDAQ:ACAD) Stock PriceSeptember 11 at 11:02 AM | marketbeat.comGreat Lakes Advisors LLC Acquires 72,667 Shares of ACADIA Pharmaceuticals Inc. $ACADSeptember 11 at 5:19 AM | marketbeat.comScientech Research LLC Has $628,000 Stock Position in ACADIA Pharmaceuticals Inc. $ACADSeptember 11 at 4:25 AM | marketbeat.comFred Alger Management LLC Increases Stock Holdings in ACADIA Pharmaceuticals Inc. $ACADSeptember 10, 2025 | marketbeat.comACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) Receives Consensus Recommendation of "Moderate Buy" from BrokeragesSeptember 10, 2025 | marketbeat.comSchizophrenia Pipeline 2025: FDA Updates, Therapy Innovations, and Clinical Trial Landscape Analysis by DelveInsight | Lundbeck, Intra-cellular Therapies, Sumitomo Pharma ...September 9, 2025 | theglobeandmail.comAssessing ACADIA Pharmaceuticals: Insights From 12 Financial AnalystsSeptember 9, 2025 | benzinga.comAcadia Pharmaceuticals price target raised to $39 from $36 at UBSSeptember 9, 2025 | msn.comBaird Financial Group Inc. Invests $1.51 Million in ACADIA Pharmaceuticals Inc. $ACADSeptember 9, 2025 | marketbeat.comComerica Bank Raises Position in ACADIA Pharmaceuticals Inc. $ACADSeptember 9, 2025 | marketbeat.comACADIA Pharmaceuticals Inc. (ACAD) Presents At Morgan Stanley 23rd Annual Global Healthcare Conference (Transcript)September 8, 2025 | seekingalpha.comAcadia Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)September 8, 2025 | businesswire.comJacobs Levy Equity Management Inc. Raises Stock Position in ACADIA Pharmaceuticals Inc. $ACADSeptember 8, 2025 | marketbeat.comWall Street Zen Downgrades ACADIA Pharmaceuticals (NASDAQ:ACAD) to HoldSeptember 8, 2025 | americanbankingnews.comNational Wealth Management Group LLC Makes New Investment in ACADIA Pharmaceuticals Inc. $ACADSeptember 7, 2025 | marketbeat.comCanada Pension Plan Investment Board Sells 491,200 Shares of ACADIA Pharmaceuticals Inc. $ACADSeptember 6, 2025 | marketbeat.comInsider Selling: ACADIA Pharmaceuticals (NASDAQ:ACAD) Director Sells 1,600 Shares of StockSeptember 5, 2025 | marketbeat.comACADIA Pharmaceuticals Inc. $ACAD Position Increased by Graham Capital Management L.P.September 5, 2025 | marketbeat.comBirchview Capital LP Has $4.38 Million Stake in ACADIA Pharmaceuticals Inc. $ACADSeptember 4, 2025 | marketbeat.comPalo Alto Investors LP Sells 84,674 Shares of ACADIA Pharmaceuticals Inc. $ACADSeptember 4, 2025 | marketbeat.comCubist Systematic Strategies LLC Has $8.69 Million Holdings in ACADIA Pharmaceuticals Inc. $ACADSeptember 4, 2025 | marketbeat.comACADIA Pharmaceuticals Inc. $ACAD Shares Sold by Trexquant Investment LPSeptember 3, 2025 | marketbeat.comPoint72 Europe London LLP Acquires 116,600 Shares of ACADIA Pharmaceuticals Inc. $ACADSeptember 2, 2025 | marketbeat.comACADIA Pharmaceuticals Inc. $ACAD Shares Sold by Walleye Capital LLCSeptember 2, 2025 | marketbeat.comNorthern Trust Corp Increases Stock Position in ACADIA Pharmaceuticals Inc. $ACADSeptember 2, 2025 | marketbeat.comHighTower Advisors LLC Invests $445,000 in ACADIA Pharmaceuticals Inc. $ACADSeptember 2, 2025 | marketbeat.comZacks Research Issues Pessimistic Estimate for ACAD EarningsSeptember 2, 2025 | marketbeat.comKodai Capital Management LP Acquires New Stake in ACADIA Pharmaceuticals Inc. $ACADSeptember 1, 2025 | marketbeat.comACADIA Pharmaceuticals Inc. $ACAD Shares Acquired by Rafferty Asset Management LLCSeptember 1, 2025 | marketbeat.comACADIA Pharmaceuticals Inc. (ACAD) Nears Phase 3 Readout in Prader-Willi Syndrome TrialAugust 29, 2025 | finance.yahoo.comVirtus Advisers LLC Sells 17,151 Shares of ACADIA Pharmaceuticals Inc. $ACADAugust 28, 2025 | marketbeat.comACADIA Pharmaceuticals (NASDAQ:ACAD) Reaches New 1-Year High - What's Next?August 27, 2025 | marketbeat.comPsychosis in Parkinson’s and Alzheimer’s Disease Market: Epidemiology, Pipeline Products, Companies, DelveInsight | Karuna Therapeutics, Sunovion Pharmaceuticals, Intra ...August 27, 2025 | theglobeandmail.comAcadia Pharmaceuticals to Participate at Upcoming Investor ConferencesAugust 26, 2025 | businesswire.comCapital Fund Management S.A. Sells 385,156 Shares of ACADIA Pharmaceuticals Inc. $ACADAugust 26, 2025 | marketbeat.comInvesco Ltd. Increases Stock Position in ACADIA Pharmaceuticals Inc. $ACADAugust 26, 2025 | marketbeat.comAcadia Pharmaceuticals Appoints Konstantina Katcheves as Senior Vice President, Chief Business and Strategy OfficerAugust 25, 2025 | businesswire.comACADIA Pharmaceuticals Inc. $ACAD Shares Bought by American Century Companies Inc.August 25, 2025 | marketbeat.comRussell Investments Group Ltd. Purchases 43,523 Shares of ACADIA Pharmaceuticals Inc. $ACADAugust 25, 2025 | marketbeat.com11,832 Shares in ACADIA Pharmaceuticals Inc. $ACAD Bought by Cetera Investment AdvisersAugust 25, 2025 | marketbeat.comCharles Schwab Investment Management Inc. Decreases Position in ACADIA Pharmaceuticals Inc. $ACADAugust 24, 2025 | marketbeat.comACADIA Pharmaceuticals (NASDAQ:ACAD) EVP Mark Schneyer Sells 22,000 SharesAugust 21, 2025 | marketbeat.com Get ACADIA Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for ACAD and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. ACAD Media Mentions By Week ACAD Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. ACAD News Sentiment▼0.940.93▲Average Medical News Sentiment ACAD News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. ACAD Articles This Week▼2512▲ACAD Articles Average Week Get the Latest News and Ratings for ACAD and Related Stocks Enter your email address to receive the latest news and analysts' ratings for ACADIA Pharmaceuticals and its competitors. Sign Up View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. Related Companies and Tools Related Companies Summit Therapeutics News Ascendis Pharma A/S News Viatris News Dr. Reddy's Laboratories News Qiagen News BridgeBio Pharma News Moderna News Elanco Animal Health News Verona Pharma PLC American Depositary Share News Roivant Sciences News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:ACAD) was last updated on 9/14/2025 by MarketBeat.com Staff From Our PartnersNvidia Times 1,000,000Nvidia’s latest AI chip is a $25,000 powerhouse — with 80 billion transistors and the ability to perform 60 tr...Paradigm Press | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredForget NVDA. Put $1,000 into this stock nowA massive money shift is underway in the AI market. And it's opening up an extraordinary opportunity in a NEW ...Chaikin Analytics | SponsoredIRS Wants Another Check on Sept 15th—What If You Could Keep It Instead?On September 15th, the IRS collects another round of quarterly tax payments—targeting self-employed profession...American Alternative | SponsoredTrump’s right about Epstein.A crisis that could devastate your wealth, upend the dollar, and accelerate the collapse of America’s economy....Porter & Company | Sponsored“Fed Proof” Your Bank Account with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredEveryone thought he was insane…SpaceX just struck a $17 billion deal with EchoStar for radio frequencies, and tech analyst Jeff Brown says it...Brownstone Research | SponsoredTrump’s new AI budget just passed — one stock could soarIn a quiet move few people noticed... President Trump just green-lit what could become the biggest AI budge...Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding ACADIA Pharmaceuticals Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share ACADIA Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.